NLPDP Stakeholder Consultations - Biosimilars Initiative (including Insulin)

NLPDP Stakeholder Consultations – Biosimilars Initiative (including Insulin)

The Newfoundland and Labrador Prescription Drug Program (NLPDP) will be holding virtual stakeholder information sessions concerning an upcoming policy change affecting reimbursement of biologic medications (including some types of insulin).

Given the role of physicians in the management of chronic conditions requiring biologic therapies, physicians are strongly encouraged to attend an upcoming session.

Virtual information sessions via Zoom will be available at the following dates and times:

  • Tuesday, February 21, at 8:00 p.m. NT
  • Thursday, February 23, at 7:00 p.m. NT

Please RSVP with a preferred date and time to Amanda Roberts at [email protected]. Once the time is confirmed, a zoom link will be provided for access to the presentation.